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Genomic data now allow the large-scale manual or semi-automated reconstruction of metabolic
networks. A network reconstruction represents a highly curated organism-specific knowledge
base. A few genome-scale network reconstructions have appeared for metabolism in the baker’s
yeast Saccharomyces cerevisiae. These alternative network reconstructions differ in scope and
content, and further have used different terminologies to describe the same chemical entities, thus
making comparisons between them difficult. The formulation of a ‘community consensus’
network that collects and formalizes the ‘community knowledge’ of yeast metabolism is thus
highly desirable. We describe how we have produced a consensus metabolic network
reconstruction for S. cerevisiae. Special emphasis is laid on referencing molecules to persistent
databases or using database-independent forms such as SMILES or InChI strings, since this
permits their chemical structure to be represented unambiguously and in a manner that permits
automated reasoning. The reconstruction is readily available via a publicly accessible database and
in the Systems Biology Markup Language, and we describe the manner in which it can be
maintained as a community resource. It should serve as a common denominator for system
biology studies of yeast. Similar strategies will be of benefit to communities studying genome-
scale metabolic networks of other organisms.
Introduction
One of the goals of integrative systems biology is the accurate representation of
biochemical, metabolic and signaling networks by mathematical models. This undertaking
can be divided into four stages 1. The first is a qualitative stage in which are listed all the
reactions that are known to occur in the system or organism of interest; in the modern era,
and especially for metabolic networks, these reaction lists are often derived in part from
genomic annotations 2, 3 with curation based on literature (‘bibliomic’) data 4. A second
stage, again qualitative, adds known effectors, while the third and fourth stages – essentially
amounting to molecular enzymology – include the known kinetic rate equations and the
values of their parameters. Armed with such information it is then possible to provide a
stochastic or ordinary differential equation model of the entire metabolic network of interest.
An attractive feature of metabolism, for the purposes of modeling, is that, in contrast to
signaling pathways, metabolism is subject to direct thermodynamic and (in particular)
stoichiometric constraints 3. Our focus here is on the first two stages of the reconstruction
process, especially as it pertains to the mapping of experimental metabolomics data onto
metabolic network reconstructions.
Besides being an industrial workhorse for a variety of biotechnological products, baker’s
yeast (Saccharomyces cerevisiae) is a highly developed model organism for biochemical,
genetic, pharmacological and post-genomic studies (e.g. 5). It is especially attractive because
of its sequenced genome 6, the availability of a whole series of bar-coded deletion 7, 8 and
other 9 strains, extensive experimental omics data (e.g. 10–14), and the ability to grow it for
extended periods in highly controlled conditions 15. The scientific community that works on
S. cerevisiae is very active and has a history of collaborative research projects that have led
to significant advances in our understanding of eukaryotic biology (e.g. 6, 8, 13, 16, 17).
Furthermore, yeast metabolic physiology has been the subject of intensive study and most of
the components of the yeast metabolic network are relatively well characterized. Taken
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together, these factors make yeast metabolism an attractive topic to test a community
approach to model building in systems biology.
A number of groups (e.g. 18–21) have reconstructed the metabolic network of yeast from
genomic and literature data and made the reconstructions freely available. However, due to
different approaches utilized in the reconstruction as well as different interpretations of the
literature, the existing reconstructions have many differences. Additionally, the naming of
metabolites and enzymes in the existing reconstructions was, at best, inconsistent, and there
were no systematic annotations of the chemical species in the form of links to external
databases that store chemical compound information. This lack of model annotation
complicated the use of the models for data analysis and integration. Members of the yeast
systems biology community therefore recognized that a single ‘consensus’ reconstruction
and annotation of the metabolic network was highly desirable as a starting point for further
investigations.
A crucial factor that enabled the building of a consensus network reconstruction is the
ability to describe and exchange biochemical network models in a standard format, the
Systems Biology Markup Language (SBML; www.sbml.org) 22. The SBML format is
utilized by most commonly used software applications for visualization, simulation, and
analysis of biochemical networks, and also in pathway databases. SBML also provides the
necessary standardized means (MIRIAM 23) to annotate models with information that is
required to identify uniquely network components, including metabolites, proteins, and
genes. Representing the consensus metabolic network reconstruction in a MIRIAM-
compatible SBML format allows widespread use of the reconstruction as well as assisting in
its continued curation, expansion and revision.
We developed this consensus reconstruction using a ‘jamboree’ approach, a large, focused
work meeting, where we defined the protocol for the curation process as well as resolving
the majority of discrepancies between the existing reconstructions. The jamboree event was
followed by an extended process of curation of remaining discrepancies and careful
annotation of components of the reconstructions by a smaller group of people. The overall
goal of the effort was, by careful curation and comprehensive annotation of the network
model and its components, to make the consensus reconstruction useful for the broadest
possible set of users. The general reconstruction could then be used directly in
bioinformatics applications aimed at integration of, for example, metabolomics and
proteomics data or as a starting point for building predictive models using a number of
different approaches (e.g. 24, 25), and for other purposes outlined below.
Here we describe how an initial ‘community consensus’ reconstruction of the yeast
metabolic network was carried out. We make some further proposals for how this
reconstruction of the yeast metabolic network may evolve as more information is acquired.
We also discuss the possibility of using a similar approach to build consensus models of
metabolic and other networks in other organisms.
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Consensus reconstruction process
As a starting point for the development of a consensus reconstruction, we chose two
separately developed freely available metabolic network reconstructions, iMM904 (http://
gcrg.ucsd.edu/In_Silico_Organisms/Yeast) and iLL672 20, containing 904 and 672 yeast
genes, respectively. Both of these reconstructions were derived from the first genome-scale
metabolic network reconstruction for yeast iFF708 18 (for the basis of this terminology
see 26), but the process of curating the original reconstruction was significantly different for
the two derived reconstructions. The iMM904 reconstruction has eight different
compartments and it was developed by curating and expanding an earlier reconstruction,
iND750 19. In contrast, the iLL672 reconstruction 20 was directly derived from iFF708 by
extensively curating the reconstruction in order to improve the ability of the flux balance
model derived from the reconstruction to predict gene deletion phenotypes 27. It should be
noted that yeast metabolic pathways in the KEGG 28 and SGD (see e.g. 29, 30) databases
were used to establish the starting point for building the original iFF708 reconstruction and
also for curating the iLL672 and iMM904 reconstructions. Hence, the information from
early versions of these two reconstructions is included implicitly in the consensus
reconstruction.
Due to the lack of common metabolite names and annotations, the comparison of the two
starting-point reconstructions required first manually defining the correspondences between
metabolites. After these had been assigned, the overall metabolite and reaction content of the
two reconstructions could be compared (Table 1). The majority of metabolites (444) were
found in both reconstructions, whereas 8 were only in iLL672 and 269 only in iMM904. In
terms of reactions, 566 were in both reconstructions, 177 reactions were only found in
iLL672, and 836 only in iMM904. The large number of additional reactions in iMM904 is
mostly due to the expanded number of compartments represented in this reconstruction.
The actual reconstruction jamboree was held at The University of Manchester, UK, in April
2007. The comparison between the iLL672 and iMM904 reconstructions shown in Table 1,
proposed at a meeting of the YSBN (www.ysbn.eu/) in Helsinki, Finland in June 2006,
formed the starting point for the reconstruction. The three-day Manchester event
concentrated on three separate areas: (1) defining standards for curation as well as for
representation of the annotated reconstruction in SBML, (2) annotating the metabolites with
reference to external compound databases, and (3) resolving discrepancies between the
reaction/metabolite sets in the two reconstructions. The presence of experts in relevant fields
such as yeast genetics and physiology, systems modeling, metabolomics, standards (SBML/
MIRIAM/metabolomics), and database/ontology development allowed the group to make
significant progress in all three areas during the event. The annotation/curation was aided by
a version of the B-Net database 31, and is provided as SBML (see Supplementary Table 1).
After the jamboree, a sub-group of the authors verified the curation/annotation and resolved
the remaining discrepancies between models. In the following we discuss in detail some of
the major components of the curation and annotation processes.
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Metabolite naming conventions
The initial comparison made it very clear that the naming conventions used in the two
models were completely different, such that it was hard in some cases even for experts to
know which chemical entities were meant. In addition, some of the reactions involved
‘generic’ structures (molecules with R-groups or so-called ‘Markush’ structures) which are
not effectively represented in stoichiometric metabolic models, while some of the named
entities represented ‘composite’ substances such as mixtures of different lipids or ‘biomass’.
Without standardized names, it is extremely hard to enable computer software to reason
about the similarities and differences between different models 32–37; this problem is even
more significant in the case of reconstructions of the larger human metabolic network
(e.g. 4, 38).
However, SBML allows one to annotate species such as metabolites with external
references, and this has permitted us to relate them to molecules in ChEBI 39, KEGG 28, and
PubChem 40, and to identify them definitively using database-independent representations of
small molecules such as SMILES 41 and InChI 36, 42. We took advantage of this aspect of
SBML to identify and annotate (manually) which chemical species were being described. In
general the procedure we followed was to search these databases with the contents of the
species’ name attribute field in the SBML representation or by the chemical formula of the
compound sought. The order of annotation was such that we annotated metabolite species
using ChEBI identifiers and InchI strings (if possible). If these did not exist or could not be
resolved, then we used KEGG IDs (or in two cases HMDB identifiers 43) followed by
PubChem IDs and finally PubMed references. This activity generated, for the first time, a
representation that allows computational comparisons to be performed.
Because some individual molecules have multiple states (e.g. because of acid-base
reactions), it would be desirable to use the chemical entities believed to be most common at
the pH of the relevant compartment. However, in this version of the consensus
reconstruction, all species are assumed to be in the form that corresponds to the most
common protonation state at pH 7.2. Whenever possible, the metabolites were annotated
with a database entry with the correct protonation state but, in a number of cases, the
databases only contained the metabolite in a neutral form or otherwise in an incorrect or
incorrectly annotated protonation state.
Annotation of large-scale metabolic models in SBML
While large-scale metabolic network reconstructions and models are now commonly
represented in SBML, there has not thus far been a standard way to annotate these models.
As part of the consensus reconstruction effort, we tried to develop such a standard that is
compliant with MIRIAM 23. While the annotation of metabolites is quite straightforward,
standardized annotation of the reaction content (molecules and reactions) of the
reconstructed network proved to be more involved.
Where possible, we annotated reactions using literature references encoded as PubMed IDs,
using the MIRIAM- and SBML-compliant "isDescribedBy" RDF annotation tag. In
addition, reaction annotations include modifiers (enzymes/enzyme complexes) where
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possible. If a given reaction can be catalyzed by two or more isozymes, we generated an
individual reaction for each isozyme (or complex). We represented the formation of protein
complexes by separate reactions. Proteins and genes were finally annotated by references to
SGD 29 and UniProt 44. In addition, we annotated cellular compartments using GO terms 45.
In all cases where annotations were used, the MIRIAM 23 web services (http://
www.ebi.ac.uk/compneur-srv/miriam-main/mdb?section=ws) were consulted to ensure
correct annotation. Examples of fully annotated species and reaction entries are shown in
Figure 2 and in Supplementary Figure 1.
Contents of the consensus reconstructions
In all, the resulting consensus network consists of 2153 species (1168 metabolites, 832
genes, 888 proteins, and 96 catalytic protein complexes) and 1857 reactions (1761 metabolic
reactions and 96 complex formation reactions). Reactions and species can be localized to 15
compartments (see Table 2) including membrane compartments. The network contains 664
distinct chemical entities (i.e. ATP is present in the nucleus, cytoplasm, Golgi,
mitochondrion, peroxisome and vacuole and as such represents 6 metabolites but here we
used just one chemical species, ignoring, e.g., Mg++ liganding). Of these distinct chemical
entities, 554 are annotated with ChEBI identifiers, 564 with InChI identifiers, 78 with
KEGG identifiers, 10 with PubChem identifiers, two with HMDB identifiers, and five only
have PubMed references. In addition, 26 compounds are currently unannotated in this way –
the majority of these are fatty acyl CoA’s or Acyl carrier proteins (ACPs) where the
corresponding fatty acid is in public databases, but the fatty acyl CoA or ACP is currently
not (but will be submitted to them).
The network includes 1312 unique chemical transformations, of which 911 occur within a
single compartment and the remaining 401 are transport reactions. The overall distribution
of metabolites and reactions between the various compartments in the consensus network is
given in Table 2. EC number and PubMed reference annotations are provided for 738 and
478 unique transformations in the network, respectively. Each reaction includes all of its
cofactors (sometimes known as ‘currency metabolites’) such as ATP, NADH and CoA. In
addition, and while we recognize that there is a certain arbitrariness about this, we have
assigned pathway names for each reaction in the network.
We have removed various reactions from the initial networks, especially where they
contained Markush structures or ambiguities. This has led to the under-representation of
lipids, where there are many combinatorial issues (e.g. 46). We anticipate that lipid pathways
will be added in the future, but “lipidomics” experiments will eventually be necessary to
define the full complement of different lipid species present in S. cerevisiae. In a similar
vein, composite items such as ‘biomass’ are excluded; while these are required for flux
balance analysis (FBA), our purpose here is to provide the basic inventory of metabolites
and network structure that can be used e.g. to compare the network with experimental
metabolomics data. This inventory can then form the basis for setting up flux balance
models using different assumptions required for setting up these kinds of model, e.g.
assumptions on the biomass composition, reversibility of reactions and lumping of the
reactions into fewer compartments.
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Figure 1 depicts the degree distribution (see e.g. 47) of the complete metabolite network, and
a version where the currency metabolites were ignored as described earlier by Wagner and
Fell 48. The complete network (Fig 1A) has an average clustering coefficient of 0.742,
average node degree of 13.166, characteristic path length of 2.186, and betweenness
centralization of 0.3897. The network without currency metabolites (Fig 1B) has an average
clustering coefficient of 0.421, average node degree of 5.138, characteristic path length of
4.178, and betweenness centralization of 0.2329. In the full network the largest value for the
shortest distance between any two metabolites (‘diameter’) is only 4 reaction steps while in
the one without “currency” metabolites it is 11 reaction steps (between dTTP and Heme A).
These statistics indicate that the “currency” metabolites should not be ignored as is
sometimes done; without them the network is considerably less connected and several
unconnected subnets appear, thus leaving some areas of metabolism unconnected from the
rest. The center metabolite in the complete network is the proton, while in the smaller one it
is coenzyme A. Table 3 lists the top 15 most-connected metabolites of each network.
Dissemination and future curation of the reconstruction
An SBML-encoded version of the base model (with and without compartments) is available
at http://www.comp-sys-bio.org/yeastnet. Specifically, the SBML representation of the
model is made available under the Creative Commons Attribution-Share Alike 3.0 Unported
License (see www.creativecommons.org/). This is the preferred source for using the
complete model with systems biology software. We have tested the SBML using various
XML validators, and shown that it loads successfully into the COPASI biochemical software
simulator 49. COPASI shows that there are a total of 307 mass conservation relations, which
were calculated from the stoichiometry matrix using the method of Vallabhajosyula 50,
which is now standard in COPASI 49. We have also loaded the model successfully into some
versions of Cytoscape 51 and CellDesigner 52. The software is fully libSBML-compliant (see
e.g. http://sbml.org/software/libsbml/ and 53, 54).
Recognizing that for many applications only subsets of this model are going to be relevant,
we also make it available in an online database that facilitates searching the model. We used
the database schema B-Net 31 which already supported all of the features required for our
SBML model, including a structured mechanism for MIRIAM annotations. This B-Net
representation of the model can be searched using synonyms and it also allows the user to
navigate through the network, for example going from a metabolite to all its reactions, then
to the genes that encode the enzymes catalyzing those reactions, etc. The database is also
available at http://www.comp-sys-bio.org/yeastnet.
The B-Net database provides another important function as it is also the preferred means by
which the community will be able to edit the model. It will thus be the primary source for
the model. The advantages of using a database for managing data are well known and need
not be reiterated here; suffice to say that, since there is no redundancy in the database, any
change in any component immediately becomes global. For the time being, editing the
model is limited to a few curators to ensure that the current standards are maintained.
However, community annotation has major benefits 55, 56. Thus we also have included at the
database a mechanism that collects annotations from anyone who wishes to communicate
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corrections or additions to the model. These annotations will then be reviewed and
incorporated into the model for future releases of new versions.
Discussion
We have brought together a large segment of the community engaged in research involving
genome-scale metabolic networks of yeast to create a consensus network that is freely
available without restrictions and that can form the basis for future improvements. The
SBML representation of the reconstruction is freely available under a Creative Commons
License, and representations of the network were designed to facilitate future improvements.
Although annotation was semi-automated, a considerable element of manual annotation was
still required, especially the parsing of the starting models. One of the biggest problems was
the use of non-standard and often arcane synonyms for referring to the same chemical entity.
A number of commentators have recognized the difficulties caused by issues of synonyms
(e.g. 4, 33, 38). For these purposes, we believe and strongly recommend that the best solution
to the synonym problem is to reference chemical entities in persistent databases and with
database-independent representations such as SMILES 41 and InChI 42. Referencing the true
chemical entity intended requires detailed consideration of its stereochemistry and the
anomeric specificity of reactions in which it is involved, and not all databases have the
required level of precision. We would also recommend that one should first build these
networks in an assumption-free manner, and only then introduce (and annotate) extra
features or assumptions that may be required for specific purposes – for instance adding
composite compounds for flux balance analyses. A further benefit of the jamboree approach
is the access to experts necessary to annotate details such as the precise gene-protein
relationships underlying specific reactions.
The reconstruction presented here is currently the most comprehensive and consistent
stoichiometric representation of yeast metabolism, from which predictive (sub)models, for
example for genome-scale flux balance analysis, can be extracted and deployed. Presently,
the reconstruction lacks information on effectors, reaction kinetics and parametrization.
However, the basic framework of B-Net coupled to SBML models that can easily be
populated with such data enables these to be added as they become available, and thus
kinetic models that can be directly linked to the genome-scale metabolic network can be
built. Some parameters are already available at SABIO-RK (http://sabio.villa-bosch.de/
SABIORK/).
Network reconstruction approaches have developed rapidly in recent years. When they reach
the genome-scale, they can be viewed as systems-level genome annotations 57. Genome-
annotation is produced by a community-driven process to reach a consensus annotation that
represents the state of knowledge about the genome of the target organism. Annotations are
then updated based on new information and they serve as a common denominator for
genome science studies of the target organism. The yeast metabolic reconstruction presented
here represents an analogous process for systems biology studies of a target organism. With
the successful achievement of the first consensus reconstruction the systems biology
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community can look forward to similar two-dimensional annotation jamborees for other
organisms.
The metabolite nomenclature proposed here will hopefully become the standard terminology
for metabolic models because the compounds themselves are essentially identical in all
species. In the present case, we believe that the semantically annotated reconstruction we
here provide will have especial utility in a number of areas. First is the basic exploration of
metabolic pathways and well-curated connections between gene products. Further, the
reconstruction will allow the automated interpretation and visualization of metabolomics
data as well as data on metabolic proteins, genes and transcripts. The network can form the
basis of phenotype predictions (including product yield) in response to genetic/
environmental perturbations using a variety of methods (including FBA and logical
approaches 58), and it can be used in metabolic flux estimation based on isotopomer data
(e.g. 59), for filling gaps in metabolic pathways, and for exploring questions related to
comparative metabolomics 60 and of metabolic pathway evolution. The widespread use of a
consensus starting point will make both the comparison and the integration of such studies
considerably easier.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Degree distribution of the metabolic network
The metabolic reaction network was first summarized in a metabolite network, where
metabolites are the nodes and one edge links two metabolites that co-occur in a reaction (in
any role as substrates or products) as described in 48. For this analysis transport steps were
not considered, nor were protein-protein binding reactions. The figures plot the distribution
of the degree of connectivity, P(k), expressed as the fraction of metabolites that have k links
out of the total number of metabolites plotted against the number of links (k) (A) in the
complete network and, (B) in a network where the following metabolites were not
considered: {water, proton, carbon dioxide, dioxygen, phosphate3−, diphosphate4−,
ammonium, ATP, ADP, AMP, NAD+, NADH, NADP+, NADPH} (to be comparable with
the analysis in 48).
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Figure 2.
An example of the SBML annotation of a metabolite species using the example of ATP, as
used in the reconstruction of the consensus network, illustrating its use of the Systems
Biology Ontology (http://www.ebi.ac.uk/sbo/) and its MIRIAM-compliance. A. Relevant
parts of the SBML code. B. An indication of the kinds of annotations included (for clarity
not all are shown).
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Table 2
Summary of the consensus reconstruction by compartment
Compartment Reactions Metabolites
Cytoplasm 835 590
Extracellular 15 158
Golgi 2 13
Mitochondrion 188 235
Nucleus 30 42
Endoplasmic reticulum 32 28
Vacuole 2 22
Peroxisome 77 80
Mitochondrial membrane 142 0
Plasma membrane 311 0
Peroxisomal membrane 44 0
ER membrane 17 0
Vacuolar membrane 35 0
Golgi membrane 5 0
Nuclear membrane 26 0
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